Daniel Shin, MD, PhD
Boston Children’s Hospital
Research Project:
Unveiling Lung Autoimmunity: Role of Regulatory T Cells in Immune Protection
Grant Awarded:
- Catalyst Award
Research Topics:
- basic biologic mechanisms
- immunology immunotherapy
Research Disease:
- ARDS
T cells are an important component of the immune system that recognize and fight infections. However, studies have found that many of these T cells can also be reactive to our own body, and if they are triggered unnecessarily or excessively, these “self-reactive” T cells can attack our healthy tissues in the form of autoimmune diseases. Importantly, the lungs appear to be prone to attack by these self-reactive T cells. Thus, better understanding of how the body prevents lung autoimmunity remains a critical goal to human health. Recently, we found that when the lung is acutely injured, a specialized subset of T cells, called regulatory T cells, accumulate in the lung to limit the ongoing immune activity. Moreover, we detected a strong expansion in the number of regulatory T cells reactive to proteins specifically expressed on the damaged lung tissue. By examining whether these self-reactive regulatory T cells persist in the lungs to limit future injury, we hope to gain new insights into how the immune system protects against the development of autoimmune diseases.
Update: We previously found that after lung injury, a specialized subset of T cells, called regulatory T cells (Tregs), accumulate in the lung to help calm the immune response. These Tregs appear to recognize the body’s own lung proteins. This suggests that the immune system, by employing a group of Tregs that are self-reactive, can determine when its activity is damaging healthy tissue and prevent further injury. In the past year, we have tracked the formation and presence of these self-reactive Tregs following acute lung injury. Our findings indicate that T cells that are reactive to proteins in the lung appear to be heavily skewed towards Tregs for months after the initial injury to the lungs. Moreover, there is a notable population of these Tregs that remain in the lungs after prior injury. We are currently investigating the characteristics of these long-lived lung-reactive Tregs and the implications of their increased presence, particularly with regard to their protection against future injury to the lungs.
Page last updated: September 22, 2025
A Breath of Fresh Air in Your Inbox
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank You!
You will now receive email updates from the American Lung Association.
